title: Repigmentation of vitiligo during efalizumab.
authors.forename: Marlies
authors.initials: M
authors.lastname: Wakkee
authors.forename: Yvette J
authors.initials: YJ
authors.lastname: Assen
authors.forename: H Bing
authors.initials: HB
authors.lastname: Thio
authors.forename: H A Martino
authors.initials: HA
authors.lastname: Neumann
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D012880:Skin Pigmentation / Q000187:drug effects*; D014820:Vitiligo / Q000150:complications / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab